Icecure Medical Ltd.NASDAQ: ICCM

IceCure's ProSense® Cryoablation Safe and Effective in Destruction of Kidney Tumors with 88.7% Recurrence-Free Rate Based on Interim ICESECRET Study Results

· Issued by Icecure Medical Ltd.
Watch Icecure Medical explain itIceCure Medical Ltd. (ICCM) Q2 2026 Earnings Call · Replay · Aug 12
  • Data confirm previous results showing that ProSense® cryoablation is highly effective for kidney tumors